Down-regulation of AMPD3 Is Associated With Poor Survival in Head and Neck Squamous Cell Carcinoma

Cheng-Ming Hsu1,2, Shun-Fu Chang3, Yao-Te Tsai1

  • 1Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan, R.O.C.

Abstract

Insights

Adenosine monophosphate deaminase 3 (AMPD3) is down-regulated in head and neck squamous cell carcinoma (HNSCC). High AMPD3 expression correlates with better survival, suggesting it may be a prognostic biomarker.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Adenosine monophosphate deaminase 3 (AMPD3) regulates cellular energy metabolism.
  • Cancer cells exhibit high energy demands.
  • The role of AMPD3 in head and neck squamous cell carcinoma (HNSCC) requires elucidation.

Purpose of the Study:

  • To investigate the expression pattern of AMPD3 in HNSCC.
  • To determine the correlation between AMPD3 expression and HNSCC tumor behavior.
  • To explore the functional role of AMPD3 in HNSCC cell lines.

Main Methods:

  • Real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) for gene expression analysis.
  • Analysis of AMPD3 expression in cancerous versus noncancerous HNSCC tissues.
  • Wound-healing and migration assays to assess cell function.

Main Results:

  • AMPD3 was significantly down-regulated in HNSCC tissues (p=0.001).
  • Lower AMPD3 expression correlated with advanced tumor and clinical stages.
  • AMPD3 knockdown reduced proliferation but increased migration and invasion in HNSCC cells.

Conclusions:

  • This study is the first to report AMPD3 expression patterns in HNSCC.
  • High AMPD3 expression may serve as a favorable prognostic biomarker for HNSCC.
  • AMPD3 exhibits antiproliferative potential, but its down-regulation may not impede HNSCC cell migration and invasion.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K